Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Gullestad

Showing results (51-60 of 382) with videos related to

Pageof 39
Sort By:
Cardiology|November 20, 2013
A pharmacokinetic and pharmacodynamic comparison of immediate-release metoprolol and extended-release metoprolol CR/XL in patients with suspected acute myocardial infarction: a randomized, open-label studyBjörn W Karlson, Mikael Dellborg, Lars Gullestad, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|May 17, 2007
Potential mechanisms of benefit with thalidomide in chronic heart failurePål Aukrust, Arne Yndestad, Jan Kristian Damås, et al.
Current Cardiology Reports|May 2, 2007
Role of inflammation in the progression of heart failureArne Yndestad, Jan Kristian Damås, Erik Øie, et al.
The American Journal of Cardiology|October 3, 2002
Effect of morning versus evening intake of simvastatin on the serum cholesterol level in patients with coronary artery diseaseTor M Lund, Harald Torsvik, Dagfinn Falch, et al.
Heart Failure Reviews|July 5, 2006
Systemic inflammation in heart failure--the whys and whereforesArne Yndestad, Jan Kristian Damås, Erik Oie, et al.
European Journal of Heart Failure|July 26, 2024
Changes in 6-min walk test is an independent predictor of death in chronic heart failure with reduced ejection fractionPeder L Myhre, Øyunn Kleiven, Kristian Berge, et al.
Expert Review of Cardiovascular Therapy|November 19, 2005
Inflammation in coronary artery disease: potential role for immunomodulatory therapyPål Aukrust, Arne Yndestad, Torgun Waehre, et al.
The American Journal of Cardiology|August 3, 2015
Contemporary Outcome in Patients With Idiopathic Dilated CardiomyopathyKaspar Broch, Klaus Murbræch, Arne Kristian Andreassen, et al.
Thrombosis and Haemostasis|May 5, 2007
Chemokines in cardiovascular risk predictionPål Aukrust, Arne Yndestad, Camilla Smith, et al.
Cardiology|June 16, 2012
Inflammatory cytokines in heart failure: mediators and markersLars Gullestad, Thor Ueland, Leif Erik Vinge, et al.
Pageof 39

Showing results (51-60 of 382) with videos related to

Sort By:
Pageof 39
Cardiology|November 20, 2013
A pharmacokinetic and pharmacodynamic comparison of immediate-release metoprolol and extended-release metoprolol CR/XL in patients with suspected acute myocardial infarction: a randomized, open-label studyBjörn W Karlson, Mikael Dellborg, Lars Gullestad, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|May 17, 2007
Potential mechanisms of benefit with thalidomide in chronic heart failurePål Aukrust, Arne Yndestad, Jan Kristian Damås, et al.
Current Cardiology Reports|May 2, 2007
Role of inflammation in the progression of heart failureArne Yndestad, Jan Kristian Damås, Erik Øie, et al.
The American Journal of Cardiology|October 3, 2002
Effect of morning versus evening intake of simvastatin on the serum cholesterol level in patients with coronary artery diseaseTor M Lund, Harald Torsvik, Dagfinn Falch, et al.
Heart Failure Reviews|July 5, 2006
Systemic inflammation in heart failure--the whys and whereforesArne Yndestad, Jan Kristian Damås, Erik Oie, et al.
European Journal of Heart Failure|July 26, 2024
Changes in 6-min walk test is an independent predictor of death in chronic heart failure with reduced ejection fractionPeder L Myhre, Øyunn Kleiven, Kristian Berge, et al.
Expert Review of Cardiovascular Therapy|November 19, 2005
Inflammation in coronary artery disease: potential role for immunomodulatory therapyPål Aukrust, Arne Yndestad, Torgun Waehre, et al.
The American Journal of Cardiology|August 3, 2015
Contemporary Outcome in Patients With Idiopathic Dilated CardiomyopathyKaspar Broch, Klaus Murbræch, Arne Kristian Andreassen, et al.
Thrombosis and Haemostasis|May 5, 2007
Chemokines in cardiovascular risk predictionPål Aukrust, Arne Yndestad, Camilla Smith, et al.
Cardiology|June 16, 2012
Inflammatory cytokines in heart failure: mediators and markersLars Gullestad, Thor Ueland, Leif Erik Vinge, et al.
Pageof 39